Aperio Group LLC Has $10.37 Million Stake in Varian Medical Systems, Inc. (NYSE:VAR)

Aperio Group LLC lowered its stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 0.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 93,268 shares of the medical equipment provider’s stock after selling 505 shares during the period. Aperio Group LLC owned 0.10% of Varian Medical Systems worth $10,367,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Thrivent Financial For Lutherans lifted its holdings in shares of Varian Medical Systems by 1.5% during the 2nd quarter. Thrivent Financial For Lutherans now owns 3,480 shares of the medical equipment provider’s stock worth $359,000 after acquiring an additional 50 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Varian Medical Systems by 0.9% during the second quarter. Dimensional Fund Advisors LP now owns 313,073 shares of the medical equipment provider’s stock valued at $32,305,000 after acquiring an additional 2,764 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its stake in shares of Varian Medical Systems by 4.5% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 3,250 shares of the medical equipment provider’s stock valued at $335,000 after acquiring an additional 141 shares during the last quarter. Bank of Nova Scotia raised its stake in shares of Varian Medical Systems by 8.2% during the second quarter. Bank of Nova Scotia now owns 20,827 shares of the medical equipment provider’s stock valued at $2,149,000 after acquiring an additional 1,585 shares during the last quarter. Finally, Nomura Holdings Inc. bought a new position in shares of Varian Medical Systems during the second quarter valued at about $931,000. Institutional investors own 99.19% of the company’s stock.

In other news, Director Timothy E. Guertin sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $111.46, for a total value of $1,114,600.00. Following the completion of the sale, the director now owns 2,161 shares in the company, valued at approximately $240,865.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark R. Laret sold 2,161 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $126.97, for a total transaction of $274,382.17. The disclosure for this sale can be found here. Insiders have sold 156,166 shares of company stock valued at $17,886,310 over the last ninety days. 0.78% of the stock is currently owned by corporate insiders.

Several equities analysts have recently commented on the stock. Royal Bank of Canada upped their price objective on shares of Varian Medical Systems to $115.00 and gave the company a “sector perform” rating in a research note on Thursday, January 25th. Citigroup boosted their price target on shares of Varian Medical Systems from $128.00 to $132.00 and gave the company a “buy” rating in a research report on Thursday, January 25th. BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, January 28th. Goldman Sachs Group cut shares of Varian Medical Systems from a “neutral” rating to a “sell” rating and set a $98.00 price objective on the stock. in a report on Thursday, January 25th. Finally, Barrington Research upgraded shares of Varian Medical Systems from a “market perform” rating to an “outperform” rating and set a $130.00 price objective on the stock in a report on Thursday, January 25th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company’s stock. Varian Medical Systems has an average rating of “Hold” and a consensus price target of $108.44.

Varian Medical Systems, Inc. (NYSE VAR) traded down $0.61 on Friday, reaching $121.26. 546,199 shares of the company’s stock traded hands, compared to its average volume of 1,102,285. The company has a market capitalization of $11,126.76, a P/E ratio of 97.01, a PEG ratio of 3.54 and a beta of 0.81. Varian Medical Systems, Inc. has a fifty-two week low of $81.55 and a fifty-two week high of $130.29.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.06. The firm had revenue of $678.50 million during the quarter, compared to analysts’ expectations of $633.96 million. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The company’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.09 earnings per share. analysts predict that Varian Medical Systems, Inc. will post 4.31 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Aperio Group LLC Has $10.37 Million Stake in Varian Medical Systems, Inc. (NYSE:VAR)” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/17/varian-medical-systems-inc-var-holdings-decreased-by-aperio-group-llc.html.

Varian Medical Systems Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply